Amgen, Bristol Myers Briggs and Vertex Pharmaceuticals were among the investors that brought the gene therapy developer’s overall funding to over $164m.

The gene therapy developer secured backing from Lundbeck and Alexandria Real Estate Equities in a series B round that will support the advancement of its clinical pipeline.

Liberty Global helped the MathCapital and Here-backed customer intelligence software provider take its series C funding to $71.5m.

MassMutual Ventures and Advance Venture Partners returned to back the relationship management tool provider’s latest round, which brought its overall funding to $120m.

Eli Lilly and Alexandria Real Estate Equities are among the investors in a round that took the protein drug developer’s total funding to over $150m.

HomeLane has now taken in over $104m of funding since it was founded, including a series E round backed by Pidilite Group.

Palantir and Leonardo have helped solar-powered aircraft technology developer Skydweller fill out its oversubscribed series A funding round.

The Ohara Pharmaceutical-backed small-molecule therapy developer has secured $11.8m from new and returning investors.

Toray Engineering has returned to back a $27.3m round for the surgical robot developer, investing alongside Dai-ichi Life and Medipal Innovation.

Myeg returned for augmented reality technology developer HiScene's $41.6m series C-plus round while celiac disease drug developer Calypso Biotech hiked a corporate-backed round to over $33m.